Dalaker K, Prydz H
Thromb Haemost. 1983 Dec 30;50(4):831-4.
Mouse placental cells are probably constitutive producers of the thromboplastin apoprotein in vitro. The effect of cyclic AMP-elevating compounds on their expression of thromboplastin activity has been studied. Dibutyryl cyclic AMP, the phosphodiesterase inhibitor Ro 20-1724 and the adenyl cyclase stimulator forskolin all decrease the synthesis of thromboplastin. Prostaglandin E2 and the phosphodiesterase inhibitor butyl-methyl-xanthine have a biphasic dose dependent effect. A stimulation was observed at low concentrations, whereas higher doses decreased the synthesis of thromboplastin. Adrenaline had no effect. Combination of two compounds, each at maximally inhibiting concentration gave no significant additive inhibitory effect, showing that they probably act via the same pathway.
小鼠胎盘细胞可能在体外组成性产生凝血活酶载脂蛋白。已研究了环磷酸腺苷(cAMP)升高化合物对其凝血活酶活性表达的影响。二丁酰环磷酸腺苷、磷酸二酯酶抑制剂Ro 20-1724和腺苷酸环化酶刺激剂福斯高林均降低凝血活酶的合成。前列腺素E2和磷酸二酯酶抑制剂丁基甲基黄嘌呤具有双相剂量依赖性作用。在低浓度时观察到刺激作用,而高剂量则降低凝血活酶的合成。肾上腺素无作用。两种化合物各自处于最大抑制浓度时联合使用,未产生显著的相加抑制作用,表明它们可能通过相同途径起作用。